There will be a CAPEX increase, an equity component raised (probably 65:35 or 60:40) and more dilution. This is not a negative either, simply the reality of financing a project of this scale.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025